A control clone was produced in parallel
Currently, there is no direct evidence on the expression of HSD17B before and after the onset of PH nor is there any sex difference in patients with PH
Chang CH, Chen MC, Lu J
In addition, pathway analysis has shown that DNA replication pathway was significantly modified, and differential gene analysis revealed that colony stimulating factor 3 (CSF3), plasminogen activator, urokinase (PLAU), ubiquitin like with PHD and ring finger domains 1 (UHRF1), FOS like 1, AP-1 transcription factor subunit (FOSL1), IL1B, dual specificity phosphatase 6 (DUSP6), minichromosome maintenance complex component (MCM)2, cyclin D1 (CCND1), Wnt family member 7B (WNT7B), MCM5, MCL1 apoptosis regulator (MCL1), SH2B adaptor protein 3 (SH2B3), MCM3, heterogeneous nuclear ribonucleoprotein M (HNRNPM), and paralemmin 2 and A-kinase anchoring protein 2 fusion (PALM2AKAP2) were upregulated and activating transcription factor 4 (ATF4), farnesyl-diphosphate farnesyltransferase 1 (FDFT1), adenylate cyclase 8 (ADCY8), cytochrome P450 family 1 subfamily B member 1 (CYP1B1), epiregulin (EREG), family with sequence similarity 114 member A1 (FAM114A1), eukaryotic translation initiation factor 4A2 (EIF4A2), aldo-keto reductase family 1 member B (AKR1B1), mitogen-activated protein kinase 1 interacting protein 1 like (C14orf132), collagen type I alpha 2 chain (COL1A2), cyclin dependent kinase inhibitor 1 A (CDKN1A), aspartate beta-hydroxylase (ASPH), DEPP autophagy regulator 1 (DEPP1), aldo-keto reductase family 1 member C1 (AKR1C1), and DNA damage inducible transcript 4 (DDIT4) were downregulated in treated SPF mice when compared to the untreated mice [253]
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
These results underscore, redox metabolism in senescence as a research area with actual therapeutic potential, and metabolomics as a powerful tool to move forwards in this field
